GO:2000178 negative regulation of neural precursor cell proliferation: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2000178 describes any biological process that stops, prevents, or reduces the frequency, rate, or extent of neural precursor cell proliferation.
• Key negative regulators include LRIG1, which attenuates EGF receptor signaling in the neocortex, and LNK, an adaptor protein that restrains neural stem cell proliferation after stroke.
• Inflammatory signals such as IL-1β can inhibit adult hippocampal neural precursor proliferation by negatively regulating TLX.
• Dysregulation of this process is linked to glioma progression, where neuronal activity promotes tumor growth via neuroligin-3 secretion.
• The NEDD4-1 gene, involved in neural precursor development, is associated with poor prognosis and chemoresistance in lung adenocarcinoma.
• Experimental models for studying this term include knockout, point-mutation, knock-in, and overexpression cell and animal systems, often combined with CRISPR screening and bioinformatics [4,6].
Description
The Gene Ontology (GO) term GO:2000178, negative regulation of neural precursor cell proliferation, defines a critical biological process that controls the size and output of neural stem and progenitor cell pools. Neural precursor cells (NPCs) are multipotent cells that give rise to neurons, astrocytes, and oligodendrocytes during development and in restricted adult neurogenic niches. Their proliferation must be tightly regulated to ensure proper brain formation and tissue homeostasis, and its dysregulation contributes to neurodevelopmental disorders and brain tumors [4,6]. Understanding the molecular players that execute this negative regulation is essential for researchers in developmental neurobiology, regenerative medicine, and neuro-oncology. This article synthesizes authoritative GO annotations and verified PubMed literature to provide a research-grade overview of GO:2000178, covering its definition, mechanisms, key genes, disease relevance, and experimental approaches including CRISPR-based models.
negative regulation of neural precursor cell proliferation At A Glance
| GO ID | GO:2000178 |
|---|---|
| GO term | negative regulation of neural precursor cell proliferation |
| Ontology | biological_process |
| Synonym | none |
| Major function | Stops, prevents, or reduces the frequency, rate, or extent of neural precursor cell proliferation |
| Related processes | Regulation of cell cycle, EGFR signaling, inflammatory signaling, Notch signaling |
| Key regulators | LRIG1, LNK, TLX, IL-1β, NEDD4-1 |
| Disease relevance | Glioma, chemoresistance, neurodevelopmental disorders |
What Is GO:2000178?
GO:2000178 is a biological process term defined as any process that stops, prevents, or reduces the frequency, rate, or extent of neural precursor cell proliferation. In other words, it encompasses all molecular events and signaling pathways that put the brakes on the division of neural stem and progenitor cells, thereby limiting the expansion of the neural precursor pool [4,6].
Why Is negative regulation of neural precursor cell proliferation Important in Cell Biology?
GO:2000178 is important because the balance between neural precursor cell proliferation and differentiation determines brain size, cortical architecture, and the capacity for adult neurogenesis. When negative regulation fails, excessive proliferation can lead to tumorigenesis, as seen in gliomas where neuronal activity promotes growth through neuroligin-3 secretion. Conversely, excessive negative regulation may deplete neural precursor pools and impair brain repair after injury or stroke. Thus, understanding this process offers insights into both cancer biology and regenerative medicine.
• Controls brain size and cortical development by limiting neural precursor expansion.
• Prevents tumorigenesis; loss of negative regulation can contribute to glioma growth.
• Regulates adult hippocampal neurogenesis, affecting learning and memory.
• Modulates the response of neural stem cells to stroke and injury.
• Involves key signaling pathways such as EGFR, which is inhibited by LRIG1.
• Links inflammation to reduced neurogenesis via IL-1β and TLX.
• Provides targets for cancer therapy, as NEDD4-1 upregulation is associated with chemoresistance.
• Informs regenerative strategies by revealing how to expand neural precursors ex vivo.
• Serves as a model for studying cell cycle exit and differentiation.
• Highlights cross-talk between cell cycle regulators and apoptotic caspases.
What Happens During negative regulation of neural precursor cell proliferation?
Initiation by extracellular cues
In simple terms: External signals tell neural precursor cells to slow down or stop dividing.
Negative regulation of neural precursor cell proliferation often begins with extracellular cues such as inflammatory cytokines or growth factor withdrawal. For example, the pro-inflammatory cytokine IL-1β acts on neural precursor cells to inhibit their proliferation, and this effect correlates with negative regulation of the transcription factor TLX. Similarly, neuronal activity in the tumor microenvironment can promote glioma growth through secretion of neuroligin-3, highlighting how external signals can override negative regulation.
Receptor-mediated inhibition of mitogenic signaling
In simple terms: Cell surface receptors dampen growth signals that would otherwise drive division.
A key step is the attenuation of mitogenic signaling pathways. LRIG1 (leucine-rich repeats and immunoglobulin-like domains 1) is a transmembrane protein that negatively regulates EGF receptor (EGFR) signaling in neural precursor cells of the neocortex. LRIG1-mediated inhibition of EGFR reduces the frequency and rate of neural precursor cell proliferation, thereby controlling cortical size. This illustrates how receptor-level inhibition directly executes GO:2000178.
Intracellular adaptor and transcription factor control
In simple terms: Inside the cell, adaptor proteins and transcription factors enforce the stop signal.
Intracellular adaptor proteins such as LNK (SH2B3) act as negative regulators of brain neural stem cell proliferation after stroke. LNK deficiency leads to increased neural stem cell proliferation, indicating that LNK normally restrains this process. Additionally, the orphan nuclear receptor TLX is negatively regulated by IL-1β, and this correlates with inhibition of adult hippocampal neural precursor cell proliferation. These intracellular events translate external cues into reduced cell cycle entry.
Cell cycle exit and cross-talk with caspases
In simple terms: The cell cycle machinery is halted, sometimes with help from apoptotic proteins.
Negative regulation ultimately converges on the cell cycle machinery to reduce proliferation. Cell-cycle cross-talk with caspases and their substrates can influence the decision between proliferation and differentiation or death. For instance, caspase substrates can modulate cell cycle progression, and their cleavage may contribute to cell cycle exit in neural precursors. This integration ensures that negative regulation is coordinated with other cellular processes.
Downstream effects on neural precursor pool size
In simple terms: The final result is fewer dividing neural precursor cells.
The cumulative effect of these steps is a reduction in the frequency, rate, or extent of neural precursor cell proliferation. This can lead to a smaller neural precursor pool, altered neurogenesis, and changes in brain architecture. For example, LRIG1-mediated inhibition of EGFR signaling regulates neural precursor cell proliferation in the neocortex, affecting the number of neurons produced. Similarly, LNK negatively regulates neural stem cell proliferation after stroke, influencing tissue repair.
Key Genes Involved in GO:2000178 negative regulation of neural precursor cell proliferation
The following genes and proteins have been experimentally implicated in the negative regulation of neural precursor cell proliferation, as supported by the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| LRIG1 | Inhibits EGFR signaling to reduce neural precursor proliferation | Controls neocortical size; target for brain tumor studies |
| LNK (SH2B3) | Adaptor protein that negatively regulates neural stem cell proliferation after stroke | Modulates injury response and neurogenesis |
| TLX (NR2E1) | Orphan nuclear receptor negatively regulated by IL-1β | Links inflammation to reduced hippocampal neurogenesis |
| IL-1β | Pro-inflammatory cytokine that inhibits neural precursor proliferation | Mediates inflammation-induced cognitive deficits |
| NEDD4-1 | E3 ubiquitin ligase involved in neural precursor development | Associated with poor prognosis and chemoresistance in lung adenocarcinoma |
| EGFR | Receptor tyrosine kinase whose signaling is attenuated by LRIG1 | Central to growth factor control of neural precursors |
| NLGN3 | Neuroligin-3, secreted by neurons to promote glioma growth | Links neuronal activity to tumor proliferation |
| Caspase-3 | Effector caspase with cell cycle cross-talk | Modulates proliferation and differentiation decisions |
| Caspase-8 | Initiator caspase involved in cell cycle regulation | Cross-talk with cell cycle machinery |
| Cyclin D1 | Cell cycle regulator promoting G1/S transition | Target of negative regulation pathways |
| p21 (CDKN1A) | Cyclin-dependent kinase inhibitor | Mediates cell cycle arrest in neural precursors |
| p27 (CDKN1B) | Cyclin-dependent kinase inhibitor | Contributes to cell cycle exit |
| Notch1 | Signaling receptor that can maintain or inhibit proliferation depending on context | Regulates neural stem cell fate |
| Sox2 | Transcription factor maintaining neural progenitor identity | Marker of neural precursors |
| Nestin | Intermediate filament protein expressed in neural precursors | Used as a marker for NPCs |
| GFAP | Astrocyte marker also expressed in radial glia-like stem cells | Identifies neural stem cells in adult niches |
| Doublecortin (DCX) | Microtubule-associated protein in immature neurons | Marker of newly generated neurons |
| Ki67 | Proliferation marker | Quantifies neural precursor proliferation |
How Is negative regulation of neural precursor cell proliferation Regulated?
The negative regulation of neural precursor cell proliferation is itself controlled by multiple signaling pathways. Inflammatory signals such as IL-1β can induce negative regulation by downregulating TLX. Growth factor signaling through EGFR is attenuated by LRIG1, which acts as a negative feedback regulator. After stroke, the adaptor protein LNK restrains neural stem cell proliferation, possibly downstream of cytokine receptors. Additionally, cell cycle checkpoints and caspase-mediated cleavage of cell cycle regulators can enforce proliferation arrest. These layers of regulation ensure that neural precursor proliferation is finely tuned to physiological demands.
negative regulation of neural precursor cell proliferation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| LRIG1 | Glioma, neocortical development | LRIG1 knockout mouse; glioma cell lines |
| LNK (SH2B3) | Stroke, impaired neurogenesis | LNK knockout mice subjected to stroke |
| TLX (NR2E1) | Neuroinflammation, cognitive decline | IL-1β treated hippocampal cultures; TLX knockout |
| NEDD4-1 | Lung adenocarcinoma, chemoresistance | NEDD4-1 overexpression in lung cancer cells |
| NLGN3 | Glioma progression | Neuron-glioma co-cultures; NLGN3 knockdown |
Glioma and brain tumors
Dysregulation of negative regulation of neural precursor cell proliferation can contribute to glioma growth. Neuronal activity promotes glioma growth through neuroligin-3 secretion, which acts on neural precursor-like cells in the tumor microenvironment. Loss of negative regulators such as LRIG1 may enhance EGFR-driven proliferation, supporting tumorigenesis. Therefore, restoring negative regulation is a potential therapeutic strategy.
Neuroinflammation and cognitive impairment
Inflammatory cytokines such as IL-1β negatively regulate adult hippocampal neural precursor proliferation by inhibiting TLX, linking neuroinflammation to reduced neurogenesis and cognitive deficits. This mechanism may underlie cognitive impairment in conditions such as chemobrain, where metformin has been investigated for its effects.
Stroke and brain repair
After stroke, neural stem cell proliferation is transiently increased, but negative regulators such as LNK act to restrain this response. Imbalance in this process may impair long-term repair and functional recovery. Understanding LNK function could inform strategies to enhance endogenous neurogenesis after injury.
Cancer chemoresistance
NEDD4-1, a gene involved in neural precursor development, is upregulated in lung adenocarcinoma and associated with poor prognosis and chemoresistance. Although this is not a neural disease, it highlights how genes related to neural precursor regulation can have broader oncogenic roles.
From negative regulation of neural precursor cell proliferation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of LRIG1 increase neural precursor proliferation? | LRIG1 knockout mouse or CRISPR KO in neural stem cells |
| Does LNK restrain neural stem cell proliferation after stroke? | LNK knockout mouse with induced stroke |
| Does IL-1β inhibit hippocampal neurogenesis via TLX? | TLX point-mutation or knockout in adult hippocampal cultures |
| Does NEDD4-1 overexpression confer chemoresistance? | NEDD4-1 overexpression in lung adenocarcinoma cell lines |
| Does neuroligin-3 secretion promote glioma growth? | NLGN3 knockdown or knockout in glioma cells co-cultured with neurons |
| Can CRISPR activation rescue negative regulation? | CRISPRa overexpression of LRIG1 or LNK in neural precursors [4,6] |
How to Study the negative regulation of neural precursor cell proliferation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| EdU/BrdU incorporation | DNA synthesis and cell proliferation | Quantify neural precursor proliferation in vitro and in vivo |
| Ki67 immunostaining | Cells in active cell cycle | Assess proliferation in tissue sections |
| RNA-seq | Global gene expression changes | Identify pathways altered by negative regulators |
| Single-cell RNA-seq | Heterogeneity of neural precursor states | Discover subpopulations responding to negative regulation |
| Proteomics | Protein abundance and modifications | Detect ubiquitination by NEDD4-1 |
| Live imaging | Dynamic behavior of neural precursors | Track proliferation and differentiation over time |
| CRISPR screening | Genes required for negative regulation | Identify novel regulators in neural stem cells [4,6] |
| Bioinformatics pathway analysis | Enrichment of GO terms and pathways | Interpret omics data in context of GO:2000178 |
Proliferation assays
Neural precursor proliferation can be measured using EdU or BrdU incorporation, Ki67 immunostaining, and cell counting. These methods quantify the frequency and rate of cell division and are used to assess negative regulation in response to genetic or pharmacological perturbations [4,6].
Transcriptomic and epigenomic profiling
RNA-seq and single-cell RNA-seq can identify changes in gene expression programs associated with negative regulation, such as downregulation of TLX target genes upon IL-1β treatment. ATAC-seq can reveal chromatin accessibility changes at proliferation-related loci.
Proteomics and ubiquitin analysis
Mass spectrometry-based proteomics can detect changes in protein abundance and post-translational modifications, such as ubiquitination mediated by NEDD4-1. This helps identify substrates and signaling nodes in negative regulation.
Imaging and lineage tracing
Live imaging of neural precursor cells expressing fluorescent reporters (e.g., Nestin-GFP) allows real-time monitoring of proliferation and differentiation. Lineage tracing in mice can determine the long-term consequences of negative regulation on neural pool size.
How CRISPR Can Be Used to Study GO:2000178 negative regulation of neural precursor cell proliferation
Knockout
CRISPR knockout of negative regulators such as LRIG1 or LNK can be used to test whether their loss increases neural precursor proliferation. For example, LRIG1 knockout in neural stem cells would be expected to enhance EGFR signaling and proliferation. LNK knockout mice show increased neural stem cell proliferation after stroke, validating its role.
Point Mutation
Point mutations can be introduced to dissect specific domains or phosphorylation sites. For instance, mutating the ubiquitin-interacting motif of NEDD4-1 could reveal its role in neural precursor regulation. Similarly, point mutations in TLX that disrupt IL-1β responsiveness could clarify its negative regulation.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) or epitope tags into endogenous loci allows visualization and purification of neural precursor cells. Tagging LRIG1 or LNK can help track their expression and interaction partners in vivo [4,6].
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can drive expression of negative regulators to assess their sufficiency in reducing proliferation. Overexpressing LRIG1 in neural precursors would be predicted to inhibit EGFR signaling and proliferation. Overexpressing NEDD4-1 in lung cancer cells can model chemoresistance.
How EDITGENE Supports negative regulation of neural precursor cell proliferation Research
Researchers studying negative regulation of neural precursor cell proliferation-related genes often need to determine whether a candidate gene is causally involved in restricting neural stem cell division. This requires precise genetic manipulation, such as knockout, point mutation, knock-in, or overexpression, followed by functional assays. EDITGENE provides end-to-end CRISPR services to accelerate such investigations.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of neural precursor cell proliferation research.
Frequently Asked Questions About negative regulation of neural precursor cell proliferation
What is GO:2000178?
GO:2000178 is a Gene Ontology term for negative regulation of neural precursor cell proliferation, defined as any process that stops, prevents, or reduces the frequency, rate, or extent of neural precursor cell proliferation [4,6].
What genes are involved in negative regulation of neural precursor cell proliferation?
Key genes include LRIG1, LNK, TLX, IL-1β, and NEDD4-1, as shown in studies of neocortical development, stroke, and neuroinflammation [4,5,6,8].
How does LRIG1 inhibit neural precursor proliferation?
LRIG1 attenuates EGF receptor signaling, thereby reducing the frequency and rate of neural precursor cell proliferation in the neocortex.
What is the role of LNK in neural stem cell proliferation?
LNK is an adaptor protein that negatively regulates brain neural stem cell proliferation after stroke; its loss increases proliferation.
How does inflammation affect neural precursor proliferation?
Inflammatory cytokine IL-1β negatively regulates TLX, which correlates with inhibition of adult hippocampal neural precursor cell proliferation.
Is negative regulation of neural precursor proliferation linked to cancer?
Yes, dysregulation can contribute to glioma growth; neuronal activity promotes glioma via neuroligin-3, and NEDD4-1 is linked to chemoresistance in lung adenocarcinoma [1,8].
What experimental models are used to study GO:2000178?
Common models include knockout mice, CRISPR knockout cell lines, point-mutation and knock-in models, and overexpression systems, combined with proliferation assays [4,6].
How can CRISPR be used to study negative regulation of neural precursor proliferation?
CRISPR knockout, point mutation, knock-in, and activation can manipulate candidate genes such as LRIG1 or LNK to test their effects on proliferation [4,6].
What methods measure neural precursor proliferation?
EdU/BrdU incorporation, Ki67 staining, and live imaging are standard methods to quantify proliferation [4,6].
Why is GO:2000178 important for brain development?
It controls the size of the neural precursor pool and cortical architecture; its disruption can lead to developmental abnormalities and disease [4,6].
Conclusion
GO:2000178, negative regulation of neural precursor cell proliferation, is a fundamental biological process that safeguards against excessive neural stem cell division. Key regulators such as LRIG1, LNK, and TLX have been identified through rigorous studies, and their dysfunction is linked to glioma, impaired neurogenesis, and chemoresistance [1,4,5,6,8]. Continued research using CRISPR-based models and multi-omics approaches will further elucidate the mechanisms and therapeutic potential of this process. EDITGENE stands ready to support these efforts with comprehensive gene editing and screening services.
References
- 1. Venkatesh HS et al.. 2015. Neuronal Activity Promotes Glioma Growth through Neuroligin-3 Secretion.. Cell 161(4):803-16 PMID: 25913192
- 3. Leddy E et al.. 2025. Investigating the effect of metformin on chemobrain: Reports from cells to bedside.. Exp Neurol 385:115129 PMID: 39733854
- 4. Jeong D et al.. 2020. LRIG1-Mediated Inhibition of EGF Receptor Signaling Regulates Neural Precursor Cell Proliferation in the Neocortex.. Cell Rep 33(2):108257 PMID: 33053360
- 5. Ryan SM et al.. 2013. Negative regulation of TLX by IL-1β correlates with an inhibition of adult hippocampal neural precursor cell proliferation.. Brain Behav Immun 33:7-13 PMID: 23510989
- 6. Ahlenius H et al.. 2012. Adaptor protein LNK is a negative regulator of brain neural stem cell proliferation after stroke.. J Neurosci 32(15):5151-64 PMID: 22496561
- 7. Connolly P et al.. 2020. Cell-Cycle Cross Talk with Caspases and Their Substrates.. Cold Spring Harb Perspect Biol 12(6) PMID: 31727679
- 8. Song YH et al.. 2018. Upregulation of Neural Precursor Cell Expressed Developmentally Downregulated 4-1 is Associated with Poor Prognosis and Chemoresistance in Lung Adenocarcinoma.. Chin Med J (Engl) 131(1):16-24 PMID: 29271375
